Kopran Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Kopran Company Profile :

Kopran Limited is an Indian based holding company engaged in the pharmaceutical business which includes products, therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others.

Company’s business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare. Company’s bulk drugs include Atenolol, Amlodipine Besylate, Metoprolol Succinate, Metoprolol Tartrate, Ceftriaxone Sodium Sterile, Doripenem, Tebipenem, Roxithromycin, Rivaroxaban, Zolmitriptan, Azithromycin, Pregabalin, Lymecycline and Nitroxoline. In addition, it offers oral care, lifestyle, beauty and personalized hygiene products.

Company’s subsidiaries include Kopran Research Laboratories Limited, Kopran (H.K) Limited and Kopran Lifesciences Limited.


Kopran Ltd ResultsBSE Code : 524280
NSE Symbol : KOPRAN
ISIN No. :  INE082A01010
Industry :  Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Kopran or you are an stock market analyst then i am sure you might for Quarterly Results of Kopran.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Kopran. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Kopran.

Kopran Q1 Results 2017-18 :

Kopran will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Kopran will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Kopran will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Kopran will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Kopran will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Kopran Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Kopran Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.